Category
Abacavir
CAS Number
141271-12-7
Molecular Formula
C₁₀H₁₄ClN₅O
Molecular Weight
255.7 g/mol
Synonym

((1S,4R)-4-((2,5-diamino-6-chloropyrimidin-4-yl)amino)cyclopent-2-en-1-yl)methanol ; Abacavir Diamine Impurity;

Keywords
Fine Chemicals
Intermediates
Pharmaceutical Standards
Impurities Manufacturer in India
Impurities
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Abacavir USP Related Compound B (CAS No.: 141271-12-7; Molecular Formula: C₁₀H₁₄ClN₅O; Molecular Weight: 255.70 g/mol) is a pharmaceutical impurity reference standard used for the identification, characterization, and quantitative determination of related substances and impurities in Abacavir drug substances and pharmaceutical formulations. It is suitable for USP impurity testing, HPLC analysis, pharmaceutical quality control, analytical method development, method validation, impurity profiling, and stability studies.

Manasa Life Sciences, an India-based manufacturer and supplier of high-purity pharmaceutical impurity reference standards, manufactures and supplies Abacavir USP Related Compound B for pharmaceutical, analytical, quality-control, and research applications. The product is manufactured and handled under stringent quality-control procedures and is supplied with essential Certificate of Analysis (CoA), batch traceability, product documentation, and analytical specifications. It supports pharmaceutical laboratories in impurity profiling, related-substance analysis, HPLC testing, analytical method development, and quality-control applications, in accordance with applicable USP–NF standards, ICH guidelines, EMA requirements, European Pharmacopoeia (Ph. Eur.) standards, and relevant GMP quality-control principles, subject to the requirements of the intended application and jurisdiction.